Follow
Zaina Qureshi
Zaina Qureshi
Assistant Professor, Arnold School of Public Health, University of South Carolina
Verified email at mailbox.sc.edu
Title
Cited by
Cited by
Year
Market withdrawal of new molecular entities approved in the United States from 1980 to 2009
ZP Qureshi, E Seoane‐Vazquez, R Rodriguez‐Monguio, KB Stevenson, ...
Pharmacoepidemiology and drug safety 20 (7), 772-777, 2011
1902011
Regulatory and clinical considerations for biosimilar oncology drugs
CL Bennett, B Chen, T Hermanson, MD Wyatt, RM Schulz, ...
The Lancet Oncology 15 (13), e594-e605, 2014
1332014
A flexible, computationally efficient method for fitting the proportional hazards model to interval-censored data
L Wang, CS McMahan, MG Hudgens, ZP Qureshi
Biometrics 72 (1), 222-231, 2016
1292016
Gadolinium-induced nephrogenic systemic fibrosis: the rise and fall of an iatrogenic disease
CL Bennett, ZP Qureshi, AO Sartor, LAB Norris, A Murday, S Xirasagar, ...
Clinical kidney journal 5 (1), 82-88, 2012
1002012
Ticlopidine-, clopidogrel-, and prasugrel-associated thrombotic thrombocytopenic purpura: a 20-year review from the Southern Network on Adverse Reactions (SONAR)
S Jacob, BL Dunn, ZP Qureshi, N Bandarenko, HC Kwaan, DK Pandey, ...
Seminars in thrombosis and hemostasis 38 (08), 845-853, 2012
942012
Acquired Idiopathic ADAMTS13 Activity Deficient Thrombotic Thrombocytopenic Purpura in a Population from Japan
M Matsumoto, CL Bennett, A Isonishi, Z Qureshi, Y Hori, M Hayakawa, ...
PloS one 7 (3), e33029, 2012
922012
Effects of women’s autonomy on maternal healthcare utilization in Bangladesh: Evidence from a national survey
MR Haider, ZP Qureshi, MM Khan
Sexual & reproductive healthcare 14, 40-47, 2017
652017
A Review of Safety, Efficacy, and Utilization of Erythropoietin, Darbepoetin, and Peginesatide for Patients with Cancer or Chronic Kidney Disease: A Report from the Southern …
CL Bennett, DM Spiegel, IC Macdougall, LA Norris, ZP Qureshi, O Sartor, ...
Seminars in thrombosis and hemostasis 38 (08), 783-796, 2012
512012
Generic oncology drugs: are they all safe?
YT Yang, S Nagai, BK Chen, ZP Qureshi, AA Lebby, S Kessler, ...
The lancet oncology 17 (11), e493-e501, 2016
502016
Clinical practice patterns on the use of magnesium sulphate for treatment of pre‐eclampsia and eclampsia: a multi‐country survey
Q Long, OT Oladapo, S Leathersich, JP Vogel, G Carroli, P Lumbiganon, ...
BJOG: An International Journal of Obstetrics & Gynaecology 124 (12), 1883-1890, 2017
472017
Linking drugs to obscure illnesses: lessons from pure red cell aplasia, nephrogenic systemic fibrosis, and Reye’s syndrome. a report from the Southern Network on Adverse …
CL Bennett, KM Starko, HS Thomsen, S Cowper, O Sartor, IC Macdougall, ...
Journal of general internal medicine 27, 1697-1703, 2012
412012
Fluoroquinolone-related neuropsychiatric and mitochondrial toxicity: a collaborative investigation by scientists and members of a social network.
K Kaur, R Fayad, A Saxena, N Frizzell, A Chanda, S Das, S Chatterjee, ...
The Journal of community and supportive oncology 14 (2), 54-65, 2016
402016
Safety and effectiveness of daptomycin across a hospitalized obese population: results of a multicenter investigation in the southeastern United States
PB Bookstaver, CM Bland, ZP Qureshi, CM Faulkner‐Fennell, ...
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 33 (12 …, 2013
402013
Polysorbate 80 hypersensitivity reactions: a renewed call to action
LAB Norris, ZP Qureshi, PB Bookstaver, DW Raisch, O Sartor, H Chen, ...
Community Oncology 9 (7), 425-428, 2010
402010
Description of anaphylactic reactions to paclitaxel and docetaxel reported to the FDA, with a focus on the role of premedication
DW Raisch, W Campbell, V Garg, ZP Qureshi, PB Bookstaver, LAB Norris, ...
Expert Opinion on Drug Safety 10 (4), 521-528, 2011
362011
Rituximab and biosimilars–equivalence and reciprocity
ZP Qureshi, JS Magwood, S Singh, CL Bennett
Biosimilars, 19-25, 2013
322013
Ticlopidine-associated ADAMTS13 activity deficient thrombotic thrombocytopenic purpura in 22 persons in Japan: a report from the Southern Network on Adverse Reactions (SONAR)
CL Bennett, S Jacob, BL Dunn, P Georgantopoulos, XL Zheng, ...
British journal of haematology 161 (6), 896, 2013
322013
Development and feasibility of an academic detailing intervention to improve prescription drug monitoring program use among physicians
KS Barth, S Ball, RS Adams, R Nikitin, NR Wooten, ZP Qureshi, ...
Journal of Continuing Education in the Health Professions 37 (2), 98-105, 2017
302017
WHO Multicountry Survey on Maternal Newborn Health Research Network. Overview of abortion cases with severe maternal outcomes in the WHO Multicountry Survey on Maternal and …
M Dragoman, WR Sheldon, Z Qureshi, J Blum, B Winikoff, B Ganatra
BJOG 121 (Suppl 1), 25-31, 2014
302014
Melanoma complicating treatment with natalizumab for multiple sclerosis: A report from the Southern Network on Adverse Reactions (SONAR)
RA Sabol, V Noxon, O Sartor, JR Berger, Z Qureshi, DW Raisch, ...
Cancer Medicine 6 (7), 1541-1551, 2017
292017
The system can't perform the operation now. Try again later.
Articles 1–20